Boston Advisors’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.76M Buy
30,626
+11,666
+62% +$646K 0.09% 274
2019
Q2
$1.03M Hold
18,960
0.05% 353
2019
Q1
$893K Sell
18,960
-3,190
-14% -$177K 0.05% 365
2018
Q4
$1.25M Buy
22,150
+2,310
+12% +$130K 0.07% 275
2018
Q3
$1.08M Sell
19,840
-445
-2% -$25.5K 0.05% 364
2018
Q2
$1.19M Buy
20,285
+1,200
+6% +$71.6K 0.03% 345
2018
Q1
$1.08M Buy
+19,085
New +$1.04M 0.03% 352
2017
Q1
Sell
-23,815
Closed -$916K 624
2016
Q4
$916K Buy
23,815
+8,005
+51% +$273K 0.02% 372
2016
Q3
$504K Sell
15,810
-185
-1% -$7.03K 0.01% 509
2016
Q2
$639K Buy
15,995
+45
+0.3% +$1.67K 0.02% 421
2016
Q1
$536K Buy
+15,950
New +$456K 0.01% 435

Other funds holding AMN

Boston Advisors's AMN Position: Q3 2019 in Review

Boston Advisors increased its AMN Healthcare (AMN) stake by 62% in Q3 2019, buying an estimated $646K and bringing the position to 30,626 shares worth $1.76M. The position accounts for 0.09% of the portfolio, ranked #274.

Boston Advisors first reported a position in AMN in Q1 2016 and has held it in 11 quarters since. 280 funds tracked by Wall St. Rank hold AMN as of Q3 2019.

  • Boston Advisors held 30,626 shares of AMN Healthcare worth $1.76M as of Q3 2019.
  • Boston Advisors bought 11,666 AMN Healthcare shares in Q3 2019, an estimated $646K.
  • AMN Healthcare made up 0.09% of Boston Advisors's portfolio in Q3 2019, its #274 holding.
  • Boston Advisors first reported a position in AMN Healthcare in Q1 2016 and has held it in 11 quarters since.
  • 280 funds tracked by Wall St. Rank held AMN Healthcare as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.